APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Piroxicam Oral Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Piroxicam Oral Tablets Market Outlook and Growth Opportunities 2026

Report ID 174026070427 December 2025195 pages

Choose your research edition.

Industry ResearchPiroxicam Oral Tablets Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Piroxicam Oral Tablets Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Piroxicam Oral Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Piroxicam Oral Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Piroxicam Oral Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Piroxicam Oral Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Piroxicam Oral Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Piroxicam Oral Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Piroxicam Oral Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Piroxicam Oral Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Piroxicam Oral Tablets market include Yunpeng Pharmaceutical Group, Shandong Fangming Pharmaceutical Group, Wanrong Pharmaceutical (Langzhi Group), Nantong Jinghua Pharmaceutical, Wellona Pharma, SK Chemical, Pfizer, Chr. Olesen Group and Adva Care Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Piroxicam Oral Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Piroxicam Oral Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Piroxicam Oral Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Piroxicam Oral Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Piroxicam Oral Tablets Segment by Company

Yunpeng Pharmaceutical Group

Shandong Fangming Pharmaceutical Group

Wanrong Pharmaceutical (Langzhi Group)

Nantong Jinghua Pharmaceutical

Wellona Pharma

SK Chemical

Pfizer

Chr. Olesen Group

Adva Care Pharma

Piroxicam Oral Tablets Segment by Type

Regular Release Tablets

Modified Release Tablets

Piroxicam Oral Tablets Segment by Application

Hospital

Clinic

Pharmacy

Piroxicam Oral Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Piroxicam Oral Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Piroxicam Oral Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Piroxicam Oral Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Piroxicam Oral Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam Oral Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Piroxicam Oral Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam Oral Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Piroxicam Oral Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Piroxicam Oral Tablets industry.

Chapter 3: Detailed analysis of Piroxicam Oral Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Piroxicam Oral Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Piroxicam Oral Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Piroxicam Oral Tablets Industry Trends Table 2. Piroxicam Oral Tablets Industry Drivers Table 3. Piroxicam Oral Tablets Industry Opportunities and Challenges Table 4. Piroxicam Oral Tablets Industry Restraints Table 5. Global Piroxicam Oral Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Piroxicam Oral Tablets Revenue Share by Company (2021-2026) Table 7. Global Piroxicam Oral Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Piroxicam Oral Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Piroxicam Oral Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Piroxicam Oral Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Piroxicam Oral Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Piroxicam Oral Tablets Company, Product Type & Application Table 13. Global Piroxicam Oral Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Piroxicam Oral Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Regular Release Tablets Table 18. Significant Companies of Modified Release Tablets Table 19. Global Piroxicam Oral Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Piroxicam Oral Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Piroxicam Oral Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Piroxicam Oral Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Piroxicam Oral Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Piroxicam Oral Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Piroxicam Oral Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Piroxicam Oral Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Piroxicam Oral Tablets Sales Value Share by Type (2021-2026) Table 28. Global Piroxicam Oral Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Pharmacy Table 32. Global Piroxicam Oral Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Piroxicam Oral Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Piroxicam Oral Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Piroxicam Oral Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Piroxicam Oral Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Piroxicam Oral Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Piroxicam Oral Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Piroxicam Oral Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Piroxicam Oral Tablets Sales Value Share by Application (2021-2026) Table 41. Global Piroxicam Oral Tablets Sales Value Share by Application (2027-2032) Table 42. Global Piroxicam Oral Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Piroxicam Oral Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Piroxicam Oral Tablets Sales Market Share by Region (2021-2026) Table 45. Global Piroxicam Oral Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Piroxicam Oral Tablets Sales Market Share by Region (2027-2032) Table 47. Global Piroxicam Oral Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Piroxicam Oral Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Piroxicam Oral Tablets Sales Value Share by Region (2021-2026) Table 50. Global Piroxicam Oral Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Piroxicam Oral Tablets Sales Value Share by Region (2027-2032) Table 52. Global Piroxicam Oral Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Piroxicam Oral Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Piroxicam Oral Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Piroxicam Oral Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Piroxicam Oral Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Piroxicam Oral Tablets Sales Market Share by Country (2021-2026) Table 58. Global Piroxicam Oral Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Piroxicam Oral Tablets Sales Market Share by Country (2027-2032) Table 60. Global Piroxicam Oral Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Piroxicam Oral Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Piroxicam Oral Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Piroxicam Oral Tablets Sales Value Market Share by Country (2027-2032) Table 64. Yunpeng Pharmaceutical Group Company Information Table 65. Yunpeng Pharmaceutical Group Business Overview Table 66. Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio Table 68. Yunpeng Pharmaceutical Group Recent Development Table 69. Shandong Fangming Pharmaceutical Group Company Information Table 70. Shandong Fangming Pharmaceutical Group Business Overview Table 71. Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio Table 73. Shandong Fangming Pharmaceutical Group Recent Development Table 74. Wanrong Pharmaceutical (Langzhi Group) Company Information Table 75. Wanrong Pharmaceutical (Langzhi Group) Business Overview Table 76. Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Product Portfolio Table 78. Wanrong Pharmaceutical (Langzhi Group) Recent Development Table 79. Nantong Jinghua Pharmaceutical Company Information Table 80. Nantong Jinghua Pharmaceutical Business Overview Table 81. Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Product Portfolio Table 83. Nantong Jinghua Pharmaceutical Recent Development Table 84. Wellona Pharma Company Information Table 85. Wellona Pharma Business Overview Table 86. Wellona Pharma Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Wellona Pharma Piroxicam Oral Tablets Product Portfolio Table 88. Wellona Pharma Recent Development Table 89. SK Chemical Company Information Table 90. SK Chemical Business Overview Table 91. SK Chemical Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. SK Chemical Piroxicam Oral Tablets Product Portfolio Table 93. SK Chemical Recent Development Table 94. Pfizer Company Information Table 95. Pfizer Business Overview Table 96. Pfizer Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pfizer Piroxicam Oral Tablets Product Portfolio Table 98. Pfizer Recent Development Table 99. Chr. Olesen Group Company Information Table 100. Chr. Olesen Group Business Overview Table 101. Chr. Olesen Group Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Chr. Olesen Group Piroxicam Oral Tablets Product Portfolio Table 103. Chr. Olesen Group Recent Development Table 104. Adva Care Pharma Company Information Table 105. Adva Care Pharma Business Overview Table 106. Adva Care Pharma Piroxicam Oral Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Adva Care Pharma Piroxicam Oral Tablets Product Portfolio Table 108. Adva Care Pharma Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Piroxicam Oral Tablets Distributors List Table 112. Piroxicam Oral Tablets Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Piroxicam Oral Tablets Product Image Figure 2. Global Piroxicam Oral Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Piroxicam Oral Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Piroxicam Oral Tablets Sales (2021-2032) & (K Units) Figure 5. Global Piroxicam Oral Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Piroxicam Oral Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Regular Release Tablets Image Figure 10. Modified Release Tablets Image Figure 11. Global Piroxicam Oral Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Piroxicam Oral Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Piroxicam Oral Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Piroxicam Oral Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Piroxicam Oral Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Piroxicam Oral Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Pharmacy Image Figure 20. Global Piroxicam Oral Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Piroxicam Oral Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Piroxicam Oral Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Piroxicam Oral Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Piroxicam Oral Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Piroxicam Oral Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Piroxicam Oral Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Piroxicam Oral Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Piroxicam Oral Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Piroxicam Oral Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Piroxicam Oral Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Piroxicam Oral Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Piroxicam Oral Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Piroxicam Oral Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Piroxicam Oral Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Piroxicam Oral Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Piroxicam Oral Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Piroxicam Oral Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Piroxicam Oral Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Piroxicam Oral Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Piroxicam Oral Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Piroxicam Oral Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Regular Release Tablets
  • Modified Release Tablets
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • Yunpeng Pharmaceutical Group
  • Shandong Fangming Pharmaceutical Group
  • Wanrong Pharmaceutical (Langzhi Group)
  • Nantong Jinghua Pharmaceutical
  • Wellona Pharma
  • SK Chemical
  • Pfizer
  • Chr. Olesen Group
  • Adva Care Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Piroxicam Oral Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Piroxicam Oral Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Piroxicam Oral Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Piroxicam Oral Tablets Market Dynamics
  1. 2.1 Piroxicam Oral Tablets Industry Trends
  2. 2.2 Piroxicam Oral Tablets Industry Drivers
  3. 2.3 Piroxicam Oral Tablets Industry Opportunities and Challenges
  4. 2.4 Piroxicam Oral Tablets Industry Restraints
3 Piroxicam Oral Tablets Market by Company
  1. 3.1 Global Piroxicam Oral Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Piroxicam Oral Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Piroxicam Oral Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Piroxicam Oral Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Piroxicam Oral Tablets Company Ranking (2024-2026)
  6. 3.6 Global Piroxicam Oral Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Piroxicam Oral Tablets Company Product Type and Application
  8. 3.8 Global Piroxicam Oral Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Piroxicam Oral Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Piroxicam Oral Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Piroxicam Oral Tablets Market by Type
  1. 4.1 Piroxicam Oral Tablets Type Introduction
  2. 4.1.1 Regular Release Tablets
  3. 4.1.2 Modified Release Tablets
  4. 4.2 Global Piroxicam Oral Tablets Sales Volume by Type
  5. 4.2.1 Global Piroxicam Oral Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Piroxicam Oral Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Piroxicam Oral Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Piroxicam Oral Tablets Sales Value by Type
  9. 4.3.1 Global Piroxicam Oral Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Piroxicam Oral Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Piroxicam Oral Tablets Sales Value Share by Type (2021-2032)
5 Piroxicam Oral Tablets Market by Application
  1. 5.1 Piroxicam Oral Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Piroxicam Oral Tablets Sales Volume by Application
  6. 5.2.1 Global Piroxicam Oral Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Piroxicam Oral Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Piroxicam Oral Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Piroxicam Oral Tablets Sales Value by Application
  10. 5.3.1 Global Piroxicam Oral Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Piroxicam Oral Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Piroxicam Oral Tablets Sales Value Share by Application (2021-2032)
6 Piroxicam Oral Tablets Regional Sales and Value Analysis
  1. 6.1 Global Piroxicam Oral Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Piroxicam Oral Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Piroxicam Oral Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Piroxicam Oral Tablets Sales by Region (2027-2032)
  5. 6.3 Global Piroxicam Oral Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Piroxicam Oral Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Piroxicam Oral Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Piroxicam Oral Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Piroxicam Oral Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Piroxicam Oral Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Piroxicam Oral Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Piroxicam Oral Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Piroxicam Oral Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Piroxicam Oral Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Piroxicam Oral Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Piroxicam Oral Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Piroxicam Oral Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Piroxicam Oral Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Piroxicam Oral Tablets Sales Value Share by Country, 2025 VS 2032
7 Piroxicam Oral Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Piroxicam Oral Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Piroxicam Oral Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Piroxicam Oral Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Piroxicam Oral Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Piroxicam Oral Tablets Sales by Country (2027-2032)
  6. 7.4 Global Piroxicam Oral Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Piroxicam Oral Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Piroxicam Oral Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Piroxicam Oral Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Piroxicam Oral Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Piroxicam Oral Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yunpeng Pharmaceutical Group
  2. 8.1.1 Yunpeng Pharmaceutical Group Company Information
  3. 8.1.2 Yunpeng Pharmaceutical Group Business Overview
  4. 8.1.3 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio
  6. 8.1.5 Yunpeng Pharmaceutical Group Recent Developments
  7. 8.2 Shandong Fangming Pharmaceutical Group
  8. 8.2.1 Shandong Fangming Pharmaceutical Group Company Information
  9. 8.2.2 Shandong Fangming Pharmaceutical Group Business Overview
  10. 8.2.3 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio
  12. 8.2.5 Shandong Fangming Pharmaceutical Group Recent Developments
  13. 8.3 Wanrong Pharmaceutical (Langzhi Group)
  14. 8.3.1 Wanrong Pharmaceutical (Langzhi Group) Company Information
  15. 8.3.2 Wanrong Pharmaceutical (Langzhi Group) Business Overview
  16. 8.3.3 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Product Portfolio
  18. 8.3.5 Wanrong Pharmaceutical (Langzhi Group) Recent Developments
  19. 8.4 Nantong Jinghua Pharmaceutical
  20. 8.4.1 Nantong Jinghua Pharmaceutical Company Information
  21. 8.4.2 Nantong Jinghua Pharmaceutical Business Overview
  22. 8.4.3 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Product Portfolio
  24. 8.4.5 Nantong Jinghua Pharmaceutical Recent Developments
  25. 8.5 Wellona Pharma
  26. 8.5.1 Wellona Pharma Company Information
  27. 8.5.2 Wellona Pharma Business Overview
  28. 8.5.3 Wellona Pharma Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wellona Pharma Piroxicam Oral Tablets Product Portfolio
  30. 8.5.5 Wellona Pharma Recent Developments
  31. 8.6 SK Chemical
  32. 8.6.1 SK Chemical Company Information
  33. 8.6.2 SK Chemical Business Overview
  34. 8.6.3 SK Chemical Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SK Chemical Piroxicam Oral Tablets Product Portfolio
  36. 8.6.5 SK Chemical Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Piroxicam Oral Tablets Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Chr. Olesen Group
  44. 8.8.1 Chr. Olesen Group Company Information
  45. 8.8.2 Chr. Olesen Group Business Overview
  46. 8.8.3 Chr. Olesen Group Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Chr. Olesen Group Piroxicam Oral Tablets Product Portfolio
  48. 8.8.5 Chr. Olesen Group Recent Developments
  49. 8.9 Adva Care Pharma
  50. 8.9.1 Adva Care Pharma Company Information
  51. 8.9.2 Adva Care Pharma Business Overview
  52. 8.9.3 Adva Care Pharma Piroxicam Oral Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Adva Care Pharma Piroxicam Oral Tablets Product Portfolio
  54. 8.9.5 Adva Care Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Piroxicam Oral Tablets Value Chain Analysis
  2. 9.1.1 Piroxicam Oral Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Piroxicam Oral Tablets Sales Mode & Process
  6. 9.2 Piroxicam Oral Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Piroxicam Oral Tablets Distributors
  9. 9.2.3 Piroxicam Oral Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst